(Nasdaq: BIIB), announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for a once-weekly lecanemab-irmb subcutaneous injection ...
To coincide with this year's Reith Lectures, entitled the Triumph of Technology, You and Yours asked what has been the most significant technological innovation since 1800. From the hundreds of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results